Scandinavian Journal of Pain
Volume 1, Issue 3 , Pages 143-148, July 2010

The effects of gabapentin in human experimental pain models

  • Thomas P. Enggaard

      Affiliations

    • Department of Anaesthesiology and Intensive Care Medicine, Odense University Hospital, Denmark
    • Clinical Pharmacology, University of Southern Denmark, Denmark
    • Corresponding Author InformationCorresponding author at: Department of Anaesthesiology and Intensive Care Medicine, Odense University Hospital, Sdr. Boulevard 29, DK-5000 Odense C, Denmark.
  • ,
  • Søren S. Mikkelsen

      Affiliations

    • Department of Anaesthesiology and Intensive Care Medicine, Odense University Hospital, Denmark
  • ,
  • Stine T. Zwisler

      Affiliations

    • Department of Anaesthesiology and Intensive Care Medicine, Odense University Hospital, Denmark
    • Clinical Pharmacology, University of Southern Denmark, Denmark
  • ,
  • Niels A. Klitgaard

      Affiliations

    • Section of Clinical Pharmacology, Clinical Biochemistry and Clinical Genetics, Odense University Hospital, Denmark
  • ,
  • Søren H. Sindrup

      Affiliations

    • Clinical Pharmacology, University of Southern Denmark, Denmark
    • Department of Neurology, Odense University Hospital, Denmark

Received 18 December 2009; received in revised form 18 April 2010; accepted 19 April 2010.

Abstract 

Background

The antidepressant drugs imipramine and venlafaxine relieve clinical neuropathic pain and have been shown to increase pain thresholds in healthy volunteers during repetitive electrical sural nerve stimulation causing temporal pain summation, whereas pain during the cold pressor test is unaltered by these drugs. If this pattern of effect in experimental pain models reflects potential efficacy in clinical neuropathic pain, the pain summation model may potentially be used to identify new drugs for such pain conditions. Gabapentinoids are evidence-based treatments of clinical neuropathic pain and could contribute with additional knowledge of the usefulness of the pain summation model.

The aim of this study

To test the analgesic effect of the gabapentinoid gabapentin in a sural nerve stimulation pain model including temporal pain summation and the cold pressor test.

Method

18 healthy volunteers completed a randomized, double-blind, cross-over trial with medication of 600mg gabapentin orally dosed 3 times over 24h against placebo. Pain tests were performed before and 24h after medication including pain detection and tolerance to single sural nerve stimulation and pain summation threshold to repetitive stimulation (3Hz). Peak pain intensity and discomfort were rated during a cold pressor test.

Results

Compared to placebo, gabapentin had a highly significant effect on the threshold of pain summation to repetitive electrical sural nerve stimulation (P=0.009). Gabapentin significantly increased the pain tolerance threshold to single electrical sural nerve stimulation (P=0.04), whereas the pain detection threshold to single electrical sural nerve stimulation tended to be increased (P=0.06). No significant differences were found on pain ratings during the cold pressor test.

Conclusion

Gabapentin had a selective hypoalgesic effect in a human experimental pain model of temporal pain summation and the results lend further support to the usefulness of the pain summation model to identify drugs for neuropathic pain.

Keywords: Human experimental pain model, Neuropathic pain, Electrical nerve stimulation, Temporal summation, Cold pressor test, Gabapentin

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Preliminary results from this study were presented as a poster at the 80th IARS Clinical and Scientific Congress, San Francisco, CA, USA, March 24–26, 2006 and at the 30th Annual Meeting, in Scandinavian Association for the Study of Pain (SASP), Stockholm, Sweden, May 4–7, 2006.

PII: S1877-8860(10)00048-0

doi:10.1016/j.sjpain.2010.04.001

Refers to article:

  • Repeated nociceptive stimulation for detecting drug effects

    Michele Curatolo
    Scandinavian Journal of Pain July 2010 (Vol. 1, Issue 3, Page 142)

Scandinavian Journal of Pain
Volume 1, Issue 3 , Pages 143-148, July 2010